SWP
GILD icon

Sagespring Wealth Partners’s Gilead Sciences GILD Stock Holding History

Sagespring Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.35M Buy
24,067
+1,122
+5% +$157K 0.06% 147
2025
Q4 		$2.82M Buy
22,945
+3,555
+18% +$432K 0.05% 159
2025
Q3 		$2.15M Buy
19,390
+2,039
+12% +$232K 0.04% 173
2025
Q2 		$1.92M Buy
17,351
+3,848
+28% +$410K 0.04% 176
2025
Q1 		$1.51M Buy
13,503
+1,563
+13% +$161K 0.04% 191
2024
Q4 		$1.1M Buy
+11,940
New +$1.08M 0.03% 203

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Sagespring Wealth Partners's GILD Position: Q1 2026 in Review

Sagespring Wealth Partners increased its Gilead Sciences (GILD) stake by 4.9% in Q1 2026, buying an estimated $157K and bringing the position to 24,067 shares worth $3.35M. The position accounts for 0.06% of the portfolio, ranked #147.

Sagespring Wealth Partners first reported a position in GILD in Q4 2024 and has held it in 6 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Sagespring Wealth Partners held 24,067 shares of Gilead Sciences worth $3.35M as of Q1 2026.
  • Sagespring Wealth Partners bought 1,122 Gilead Sciences shares in Q1 2026, an estimated $157K.
  • Gilead Sciences made up 0.06% of Sagespring Wealth Partners's portfolio in Q1 2026, its #147 holding.
  • Sagespring Wealth Partners first reported a position in Gilead Sciences in Q4 2024 and has held it in 6 quarters since.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Sagespring Wealth Partners's 13F filing for Q1 2026, filed 7 May 2026.